NAYA Biosciences Inc
NASDAQ:NAYA

Watchlist Manager
NAYA Biosciences Inc Logo
NAYA Biosciences Inc
NASDAQ:NAYA
Watchlist
Price: 2.74 USD 17.09% Market Closed
Market Cap: 21.9m USD

NAYA Biosciences Inc
Investor Relations

INVO BioScience, Inc. is a fertility company. The company is headquartered in Sarasota, Florida and currently employs 25 full-time employees. The company went IPO on 2008-11-11. The Company’s initial pipeline includes two novel Flex-NK Bispecific Antibodies. NY-303: its GPC3-targeted FLEX-NK Bispecific Antibody for Hepatocellular Carcinoma (HCC). NY-338: its CD38-targeted FLEX-NK Bispecific Antibody for Multiple Myeloma (MM) & Autoimmune Diseases. Its lead GPC3-targeting FLEX-NK bispecific antibody is entering Phase I/II clinical trials and positioned as a monotherapy option to address the unmet needs of the of hepatocellular carcinoma (HCC) patients not responding to standard of care with checkpoint inhibitors. INVOcell is its novel, FDA-cleared and CE-marked intravaginal culture (IVC) device. The company offers a viable alternative to vitro fertilization (IVF) that uses the female body for fertilization and incubation, keeping women at the center of the reproductive process.

Show more
Loading

Earnings Calls

No Earnings Calls Available

Management

Mr. Steven M. Shum
CEO & Director
No Bio Available
Dr. Daniel Gedeon Teper MBA, PharmD
President & Director
No Bio Available
Mr. Andrea Goren
Chief Financial Officer
No Bio Available
Ms. Anna Baran-Djokovic J.D.
Senior Vice President of Investor Relations
No Bio Available

Contacts

Address
FLORIDA
Sarasota
5582 Broadcast Court
Contacts